Logo image of DRIO

DARIOHEALTH CORP (DRIO) Stock Price, Quote, News and Overview

NASDAQ:DRIO - Nasdaq - US23725P2092 - Common Stock - Currency: USD

0.75  +0.05 (+7.14%)

DRIO Quote, Performance and Key Statistics

DARIOHEALTH CORP

NASDAQ:DRIO (4/17/2025, 8:14:08 PM)

0.75

+0.05 (+7.14%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
Statistics
52 Week High1.93
52 Week Low0.5
Market Cap31.18M
Shares41.57M
Float32.69M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-13 2025-05-13/bmo
IPO03-08 2013-03-08


DRIO short term performance overview.The bars show the price performance of DRIO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20

DRIO long term performance overview.The bars show the price performance of DRIO in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of DRIO is 0.75 USD. In the past month the price increased by 6.32%. In the past year, price decreased by -35.34%.

DARIOHEALTH CORP / DRIO Daily stock chart

DRIO Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
VEEV VEEVA SYSTEMS INC-CLASS A 32.67 35.14B
DOCS DOXIMITY INC-CLASS A 41.57 9.98B
WAY WAYSTAR HOLDING CORP N/A 6.27B
CERT CERTARA INC 31.44 2.28B
SDGR SCHRODINGER INC N/A 1.88B
GDRX GOODRX HOLDINGS INC-CLASS A 13.59 1.72B
PHR PHREESIA INC N/A 1.41B
TDOC TELADOC HEALTH INC N/A 1.20B
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A 1.08B
EVH EVOLENT HEALTH INC - A 13.58 1.04B
HSTM HEALTHSTREAM INC 49.08 988.87M
CCLDO CARECLOUD INC - CCLD 8 3/4 PERP N/A 787.15M

About DRIO

Company Profile

DRIO logo image DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company is headquartered in New York City, New York and currently employs 196 full-time employees. The company went IPO on 2013-03-08. The firm operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.

Company Info

DARIOHEALTH CORP

322 W 57Th St. #33B

New York City NEW YORK 10019 US

CEO: Erez Raphael

Employees: 223

Company Website: https://shop.mydario.com/

Investor Relations: https://dariohealth.investorroom.com

Phone: 16466654667

DARIOHEALTH CORP / DRIO FAQ

What is the stock price of DARIOHEALTH CORP today?

The current stock price of DRIO is 0.75 USD. The price increased by 7.14% in the last trading session.


What is the ticker symbol for DARIOHEALTH CORP stock?

The exchange symbol of DARIOHEALTH CORP is DRIO and it is listed on the Nasdaq exchange.


On which exchange is DRIO stock listed?

DRIO stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for DARIOHEALTH CORP stock?

9 analysts have analysed DRIO and the average price target is 2.72 USD. This implies a price increase of 262.67% is expected in the next year compared to the current price of 0.75. Check the DARIOHEALTH CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is DARIOHEALTH CORP worth?

DARIOHEALTH CORP (DRIO) has a market capitalization of 31.18M USD. This makes DRIO a Nano Cap stock.


How many employees does DARIOHEALTH CORP have?

DARIOHEALTH CORP (DRIO) currently has 223 employees.


What are the support and resistance levels for DARIOHEALTH CORP (DRIO) stock?

DARIOHEALTH CORP (DRIO) has a resistance level at 0.76. Check the full technical report for a detailed analysis of DRIO support and resistance levels.


Is DARIOHEALTH CORP (DRIO) expected to grow?

The Revenue of DARIOHEALTH CORP (DRIO) is expected to grow by 20.99% in the next year. Check the estimates tab for more information on the DRIO EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy DARIOHEALTH CORP (DRIO) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does DARIOHEALTH CORP (DRIO) stock pay dividends?

DRIO does not pay a dividend.


When does DARIOHEALTH CORP (DRIO) report earnings?

DARIOHEALTH CORP (DRIO) will report earnings on 2025-05-13, before the market open.


What is the Price/Earnings (PE) ratio of DARIOHEALTH CORP (DRIO)?

DARIOHEALTH CORP (DRIO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.62).


What is the Short Interest ratio of DARIOHEALTH CORP (DRIO) stock?

The outstanding short interest for DARIOHEALTH CORP (DRIO) is 10.06% of its float. Check the ownership tab for more information on the DRIO short interest.


DRIO Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to DRIO. When comparing the yearly performance of all stocks, DRIO is a bad performer in the overall market: 69.06% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

DRIO Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to DRIO. DRIO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

DRIO Financial Highlights

Over the last trailing twelve months DRIO reported a non-GAAP Earnings per Share(EPS) of -0.62. The EPS increased by 69.31% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -34.47%
ROE -56.9%
Debt/Equity 0.33
Chartmill High Growth Momentum
EPS Q2Q%82%
Sales Q2Q%110.29%
EPS 1Y (TTM)69.31%
Revenue 1Y (TTM)32.84%

DRIO Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 82% to DRIO. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 44.06% and a revenue growth 20.99% for DRIO


Ownership
Inst Owners29.96%
Ins Owners8.82%
Short Float %10.06%
Short Ratio3.14
Analysts
Analysts82.22
Price Target2.72 (262.67%)
EPS Next Y44.06%
Revenue Next Year20.99%